Vivimed Labs inks agreements to facilitate investment of $42.5 million

26 Sep 2017 Evaluate

Vivimed Labs has signed definitive agreements to facilitate an investment of $42.5 million by OrbiMed Asia into the Company’s subsidiary, Vivimed Labs Mascarene, the holding entity of the company’s API business, UQUIFA.

The proceeds of this fund raise will be utilized by the company primarily for Debt reduction and optimization of capital structure at the parent entity level and investment in the API business for capacity augmentation and organic growth.

Vivimed Labs is engaged in providing specialty chemicals and pharmaceuticals products. The company offers products for oral care, sun care, skin care, hair care, reversacol photochromic dyes, imaging chemicals and nisarg.


Vivimed Labs Share Price

7.00 -0.36 (-4.89%)
22-Jan-2026 12:26 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1622.65
Dr. Reddys Lab 1222.20
Cipla 1378.85
Zydus Lifesciences 885.25
Lupin 2176.70
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×